Development of fetal neural transplantation as a treatment for Parkinson's disease (Q33809293)

29 July 2017

1 reference

title

Development of fetal neural transplantation as a treatment for Parkinson's disease (English)

1 reference

29 July 2017

1 reference

Clarkson ED

1

1 reference

29 July 2017

Freed CR

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

65

1 reference

29 July 2017

issue

23

1 reference

29 July 2017

page(s)

2427-2437

1 reference

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Aromatic Amino Acids and Modification of Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Pallidal and thalamic surgery for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Deep brain stimulation for movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Functional activity of substantia nigra grafts reinnervating the striatum: neurotransmitter metabolism and [14C]2-deoxy-D-glucose autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Reversal of parkinsonism by fetal nerve cell transplants in primate brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Fetal nigral transplantation as a therapy for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Caspase inhibition reduces apoptosis and increases survival of nigral transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900254-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(99)00254-4

1 reference

29 July 2017

1 reference